Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,34 USD | -8,11 % | -39,39 % | -82,56 % |
28/03 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
18/03 | AGILE THERAPEUTICS, INC. : Maxim da una recomendación neutral | ZM |
Resumen de negocios
Número de empleados: 22
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Transdermal Patch
100,0
%
| 4 | 100,0 % | 11 | 100,0 % | +165,40 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 11 | 100,0 % | +165,40 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 01/02/04 |
Scott Coiante
DFI | Director of Finance/CFO | 57 | 01/12/10 |
Paul Korner
CTO | Chief Tech/Sci/R&D Officer | 58 | 17/08/20 |
Chief Administrative Officer | 58 | 01/08/14 | |
Matthew Riley
IRC | Investor Relations Contact | - | 02/01/20 |
Amy Welsh
PRN | Corporate Officer/Principal | 53 | 01/05/20 |
Kimberly Whelan
PRN | Corporate Officer/Principal | - | 01/12/19 |
Joseph D’Urso
AUD | Comptroller/Controller/Auditor | - | 01/10/14 |
Robert Conway
PRN | Corporate Officer/Principal | 67 | 01/01/04 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 01/02/04 |
Seth Fischer
BRD | Director/Board Member | 68 | 28/07/16 |
John Hubbard
BRD | Director/Board Member | 67 | 18/11/14 |
Sandra A. Carson
BRD | Director/Board Member | 70 | 09/06/20 |
Director/Board Member | 58 | 07/10/21 | |
Sharon Barbari
BRD | Director/Board Member | 70 | 09/06/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 511 657 | 2 481 299 ( 98,79 %) | 0 | 98,79 % |
Acción B | 0 | 4 850 | 0 | 4 850 ( 100,00 %) |
Información de la empresa
Agile Therapeutics, Inc.
500 College Road East Suite 310
08540-1715, Princeton
+609 683 1880
http://www.agiletherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-82,56 % | 2,22 M | |
+2,73 % | 108 mil M | |
+9,59 % | 103 mil M | |
+6,58 % | 23,48 mil M | |
-12,59 % | 21,93 mil M | |
-3,29 % | 19,68 mil M | |
-35,36 % | 18,37 mil M | |
-13,29 % | 16,33 mil M | |
+4,68 % | 13,72 mil M | |
+34,25 % | 12,15 mil M |
- Bolsa
- Acciones
- Acción Agile Therapeutics, Inc. - OTC Markets
- Empresa Agile Therapeutics, Inc.